Mono Pharmacare Limited (NSE:MONOPHARMA)

Market Cap	187.29M -67.0%
Revenue (ttm)	1.48B +3.1%
Net Income	8.33M -71.0%
EPS	0.43 -73.1%
Shares Out	17.67M
PE Ratio	24.37
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	10.30
Previous Close	10.60
Day's Range	10.25 - 10.30
52-Week Range	9.45 - 27.50
Beta	-0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 9, 2026

About Mono Pharmacare

Mono Pharmacare Limited engages in the distribution of pharmaceutical items in India. The company markets healthcare products, such as antibiotics, cough cold anti allergics, antifungal, nutraceutical, analgesic and antipyretic, antacid and antiemetic, cardiac diabetic, skincare, antiseptic, bronchodilators, probiotics, and antihistamines. It also offers products under the Cosmo Care brand; eye and ear drops, nasal spray, gynec, herbal, and skincare products. The company was founded in 1964 and is based in Ahmedabad, India.

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1964
• Employees: 115
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MONOPHARMA

Financial Performance

In fiscal year 2025, Mono Pharmacare's revenue was 1.68 billion, an increase of 37.65% compared to the previous year's 1.22 billion. Earnings were 30.90 million, an increase of 26.52%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 14, 2026

Data Sources Report a data error